Overview

• Peru’s Health Ministry launched a free, nationwide screening campaign for breast, cervical, prostate, colon and skin cancers throughout October, led by Dpcan director Essy Maradiegue, with early activity reported in Lima’s San Juan de Lurigancho.
• Andalusia activated a €12 million plan to review delayed breast screening communications and scheduling, pledging checks for 2,000 affected patients within two months and adding 119 staff, a move endorsed by the regional oncology society SAOM.
• Nuevo León reported outcomes from its universal breast-cancer program since April 2022, citing 1,730 beneficiaries, 49,000 mammograms, 1,293 surgeries and 233 reconstructions, alongside a lower state mortality rate of 23.6 per 100,000 women aged 25 and over.
• Clinic Barcelona is preparing the first clinical study of an antibody‑drug conjugate developed in Spain for HR+/HER2‑ metastatic breast cancer, with €150,000 in patient-backed funding, though efficacy in patients remains to be proven.
• Spain’s national breast cancer federation Fecma called for adequately resourced, quality‑controlled and homogeneous screening programs, faster access to innovative therapies and a more equitable public system across regions.